Revenues of Lexaria Bioscience Corp. from 29 Feb 2016 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Lexaria Bioscience Corp. quarterly and annual Revenues in USD history and change rate from 29 Feb 2016 to 30 Nov 2025.
  • Lexaria Bioscience Corp. Revenues for the quarter ending 30 Nov 2025 was $0, a 100% decline year-over-year.
  • Lexaria Bioscience Corp. Revenues for the twelve months ending 30 Nov 2025 was $522,000, a 5% increase year-over-year.
  • Lexaria Bioscience Corp. annual Revenues for 2025 was $705,923, a 52% increase from 2024.
  • Lexaria Bioscience Corp. annual Revenues for 2024 was $464,278, a 105% increase from 2023.
  • Lexaria Bioscience Corp. annual Revenues for 2023 was $226,208, a 11% decline from 2022.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

Lexaria Bioscience Corp. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $522,000 $0 -$183,923 -100% 01 Sep 2025 30 Nov 2025 10-Q 13 Jan 2026 2026 Q1
Q3 2025 $705,923 $174,000 +$90,000 +107% 01 Jun 2025 31 Aug 2025 10-K 28 Nov 2025 2025 FY
Q2 2025 $615,923 $174,000 +$90,000 +107% 01 Mar 2025 31 May 2025 10-Q 14 Jul 2025 2025 Q3
Q1 2025 $525,923 $174,000 +$29,000 +20% 01 Dec 2024 28 Feb 2025 10-Q 14 Apr 2025 2025 Q2
Q4 2024 $496,923 $183,923 +$32,645 +22% 01 Sep 2024 30 Nov 2024 10-Q 13 Jan 2026 2026 Q1
Q3 2024 $464,278 $84,000 +$53,259 +173% 01 Jun 2024 31 Aug 2024 10-K 28 Nov 2025 2025 FY
Q2 2024 $411,019 $84,000 +$6,293 +8.1% 01 Mar 2024 31 May 2024 10-Q 14 Jul 2025 2025 Q3
Q1 2024 $404,726 $145,000 +$124,975 +624% 01 Dec 2023 29 Feb 2024 10-Q 14 Apr 2025 2025 Q2
Q4 2023 $279,751 $151,278 +$53,543 +55% 01 Sep 2023 30 Nov 2023 10-Q 10 Jan 2025 2025 Q1
Q3 2023 $226,208 $30,741 -$80,409 -72% 01 Jun 2023 31 Aug 2023 10-K 26 Nov 2024 2024 FY
Q2 2023 $306,617 $77,707 -$22,010 -22% 01 Mar 2023 31 May 2023 10-Q 12 Jul 2024 2024 Q3
Q1 2023 $328,627 $20,025 -$10,625 -35% 01 Dec 2022 28 Feb 2023 10-Q 09 Apr 2024 2024 Q2
Q4 2022 $339,252 $97,735 +$83,855 +604% 01 Sep 2022 30 Nov 2022 10-Q 12 Jan 2024 2023 Q1
Q3 2022 $255,397 $111,150 +$80,129 +258% 01 Jun 2022 31 Aug 2022 10-K 20 Nov 2023 2023 FY
Q2 2022 $175,268 $99,717 -$104,338 -51% 01 Mar 2022 31 May 2022 10-Q 14 Jul 2023 2023 Q3
Q1 2022 $279,606 $30,650 -$161,356 -84% 01 Dec 2021 28 Feb 2022 10-Q 14 Apr 2023 2023 Q2
Q4 2021 $440,962 $13,880 -$281,776 -95% 01 Sep 2021 30 Nov 2021 10-Q/A 18 Jan 2023 2023 Q1
Q3 2021 $722,738 $31,021 01 Jun 2021 31 Aug 2021 10-K 28 Nov 2022 2022 FY
Q2 2021 $204,055 01 Mar 2021 31 May 2021 10-Q 14 Jul 2022 2022 Q3
Q1 2021 $192,006 01 Dec 2020 28 Feb 2021 10-Q 11 Apr 2022 2022 Q2
Q4 2020 $295,656 01 Sep 2020 30 Nov 2020 10-Q 14 Jan 2022 2022 Q1
Q2 2018 $140,340 +$111,087 +380% 01 Mar 2018 31 May 2018 10-Q 13 Jul 2018 2018 Q3
Q1 2018 $171,958 +$159,356 +1265% 01 Dec 2017 28 Feb 2018 10-Q 12 Apr 2018 2018 Q2
Q4 2017 $24,635 +$15,410 +167% 01 Sep 2017 30 Nov 2017 10-Q 12 Jan 2018 2018 Q1
Q2 2017 $29,253 +$23,038 +371% 01 Mar 2017 31 May 2017 10-Q 13 Jul 2018 2018 Q3
Q1 2017 $12,602 -$2,552 -17% 29 Nov 2016 28 Feb 2017 10-Q 14 Apr 2017 2017 Q2
Q4 2016 $9,225 01 Sep 2016 30 Nov 2016 10-Q 12 Jan 2018 2018 Q1
Q2 2016 $6,215 01 Mar 2016 31 May 2016 10-Q 14 Jul 2017 2017 Q3
Q1 2016 $15,154 01 Dec 2015 29 Feb 2016 10-Q 14 Apr 2017 2017 Q2

Lexaria Bioscience Corp. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $705,923 +$241,645 +52% 01 Sep 2024 31 Aug 2025 10-K 28 Nov 2025 2025 FY
2024 $464,278 +$238,070 +105% 01 Sep 2023 31 Aug 2024 10-K 28 Nov 2025 2025 FY
2023 $226,208 -$29,189 -11% 01 Sep 2022 31 Aug 2023 10-K 26 Nov 2024 2024 FY
2022 $255,397 -$467,341 -65% 01 Sep 2021 31 Aug 2022 10-K 20 Nov 2023 2023 FY
2021 $722,738 +$407,945 +130% 01 Sep 2020 31 Aug 2021 10-K 28 Nov 2022 2022 FY
2020 $314,793 01 Sep 2019 31 Aug 2020 10-K 29 Nov 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.